| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 9,096,914 | 12,017,549 | 16,240,568 | | Cost of Revenue | 3,413,292 | 4,494,431 | 6,228,444 | | | Gross Profit | 5,683,622 | 7,523,118 | 10,012,124 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,453,623 | 1,796,869 | 3,251,283 | | Non Recurring |
-
|
-
|
-
| | Others | 1,418,524 | 1,693,284 | 2,591,077 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,811,475 | 4,032,965 | 4,169,765 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (59,953) | 356,045 | 554,536 | | Earnings Before Interest And Taxes | 2,746,969 | 4,362,011 | 4,928,303 | | Interest Expense | 582,426 | 639,345 | 783,433 | | Income Before Tax | 2,164,543 | 3,722,666 | 4,144,870 | | Income Tax Expense | 714,482 | 1,087,542 | 1,532,408 | | Minority Interest | 3,875 | 17 | 107,208 | | | | Net Income From Continuing Ops | 1,453,937 | 2,663,725 | 2,561,632 | | | Non-recurring Events | | Discontinued Operations | 159,269 | 587,257 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,613,205 | 3,250,983 | 2,561,632 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,613,205 | $3,250,983 | $2,561,632 |
|
0.02% Nasdaq 
Income Statement
